SMARTPHLEX - Technology-enabled Smart Solutions - Part 2

At PharmaLex we have the technology, know-how and experience to take these raw ingredients and realize real, immediate and lasting benefits for our clients – we call this SMARTPHLEX.

Posted:

SMARTPHLEX - Technology-enabled Smart Solutions

At PharmaLex we have the technology, know-how and experience to take these raw ingredients and realize real, immediate and lasting benefits for our clients – we call this SMARTPHLEX.

Posted:

SMARTRISK

SMARTRISK was developed as a response to the EU guidance that was published in 2015 regarding excipient risk assessment for medicinal products to provide a way of performing the risk assessment in a compliant manner, but that was easy for the user.

Posted:

FORBES LEADER’S TALK: The challenges of the biotech market

Sophie Guillaume, General Manager and Patrick Larcier, Senior Director, Drug Development & Vigilance, PharmaLex France, discuss the challenges of the biotech market

Posted:

Who are PharmaLex and what do we do?

As a specialized provider, the services PharmaLex offers are essential to enable companies to maximize their development process and reduce their time to market.

This animation will give you a short overview of who we are, what we do and how we can support your company.

Posted: